Monoclonal Antibody Therapeutics Market Size, Share, Forecast, Demand, Analysis 2032
Monoclonal Antibody Therapeutics Market By Application(Cancer, Autoimmune Diseases, Infection, Hematological Diseases, Others), By Source(Human, Humanized, Chimeric, Others), By End User(Hospitals, Private Clinics, Research Institute), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 231.48 Billion | USD 706.52 Billion | 13.2% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Global Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
- 2.2. Global Monoclonal Antibody Therapeutics Market: Snapshot
- Chapter 3. Monoclonal Antibody Therapeutics Market- Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Global Monoclonal Antibody Therapeutics Market Drivers: Impact Analysis
- 3.2.2. Growing Monoclonal Antibody Therapeutics Consumption in Developing Countries
- 3.2.3. Changing Consumption Habits of Monoclonal Antibody Therapeutics
- 3.3. Market Restraints
- 3.3.1. Global Monoclonal Antibody Therapeutics Market Restraints: Impact Analysis
- 3.3.2. High Taxation in Monoclonal Antibody Therapeutics Business and Trade
- 3.4. Opportunities
- 3.4.1. Innovative Products with Flavored Monoclonal Antibody Therapeutics
- 3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat from New Entrants
- 3.5.4. Threat from New Substitutes
- 3.5.5. Degree of Competition
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market Attractiveness Analysis, by Application Segment
- 3.6.2. Market Attractiveness Analysis, by Source Segment
- 3.6.3. Market Attractiveness Analysis, by End User Segment
- 3.6.4. Market Attractiveness Analysis, by Regional Segment
- Chapter 4. Global Monoclonal Antibody Therapeutics Market- Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Monoclonal Antibody Therapeutics Market: Company Market Share, 2017
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Product Launch
- 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
- 4.2.4. Research and Development and Regional Expansion
- 4.3. Price Trend Analysis
- 4.1. Company Market Share Analysis
- Chapter 5. Global Monoclonal Antibody Therapeutics Market- Application Segment Analysis
- 5.1. Global Monoclonal Antibody Therapeutics Market: Application Overview
- 5.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by Application, 2017 and 2023
- 5.2. Cancer
- 5.2.1. Global Monoclonal Antibody Therapeutics Market for Cancer, 2015 - 2023 (USD Billion)
- 5.3. Autoimmune Diseases
- 5.3.1. Global Monoclonal Antibody Therapeutics Market for Autoimmune Diseases, 2015 - 2023 (USD Billion)
- 5.4. Infection
- 5.4.1. Global Monoclonal Antibody Therapeutics Market for Infection, 2015 - 2023 (USD Billion)
- 5.5. Hematological Diseases
- 5.5.1. Global Monoclonal Antibody Therapeutics Market for Hematological Diseases, 2015 - 2023 (USD Billion)
- 5.6. Others
- 5.6.1. Global Monoclonal Antibody Therapeutics Market for Others, 2015 - 2023 (USD Billion)
- 5.1. Global Monoclonal Antibody Therapeutics Market: Application Overview
- Chapter 6. Global Monoclonal Antibody Therapeutics Market- Source Segment Analysis
- 6.1. Global Monoclonal Antibody Therapeutics Market: Source Overview
- 6.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by Source, 2017 and 2023
- 6.2. Human
- 6.2.1. Global Monoclonal Antibody Therapeutics Market for Human, 2015 - 2023 (USD Billion)
- 6.3. Humanized
- 6.3.1. Global Monoclonal Antibody Therapeutics Market for Humanized, 2015 - 2023 (USD Billion)
- 6.4. Chimeric
- 6.4.1. Global Monoclonal Antibody Therapeutics Market for Chimeric, 2015 - 2023 (USD Billion)
- 6.5. Others
- 6.5.1. Global Monoclonal Antibody Therapeutics Market for Others, 2015 - 2023 (USD Billion)
- 6.1. Global Monoclonal Antibody Therapeutics Market: Source Overview
- Chapter 7. Global Monoclonal Antibody Therapeutics Market- End User Segment Analysis
- 7.1. Global Monoclonal Antibody Therapeutics Market: End User Overview
- 7.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by End User, 2017 and 2023
- 7.2. Hospitals
- 7.2.1. Global Monoclonal Antibody Therapeutics Market for Hospitals, 2015 - 2023 (USD Billion)
- 7.3. Private Clinics
- 7.3.1. Global Monoclonal Antibody Therapeutics Market for Private Clinics, 2015 - 2023 (USD Billion)
- 7.4. Research Institutes
- 7.4.1. Global Monoclonal Antibody Therapeutics Market for Research Institutes, 2015 - 2023 (USD Billion)
- 7.1. Global Monoclonal Antibody Therapeutics Market: End User Overview
- Chapter 8. Global Monoclonal Antibody Therapeutics Market- Regional Segment Analysis
- 8.1. Global Monoclonal Antibody Therapeutics Market: Regional Overview
- 8.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by Region, 2017 And 2023
- 8.2. North America
- 8.2.1. North America Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
- 8.2.2. North America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.2.3. North America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.2.4. North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.2.5. U.S.
- 8.2.5.1. U.S. Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.2.5.2. U.S. Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.2.5.3. U.S. Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.2.6. Rest of North America
- 8.2.6.1. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.2.6.2. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.2.6.3. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.3. Europe
- 8.3.1. Europe Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
- 8.3.2. Europe Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.3.3. Europe Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.3.4. Europe Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.3.5. UK
- 8.3.5.1. UK Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.3.5.2. UK Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.3.5.3. UK Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.3.6. Germany
- 8.3.6.1. Germany Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.3.6.2. Germany Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.3.6.3. Germany Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.3.7. France
- 8.3.7.1. France Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.3.7.2. France Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.3.7.3. France Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.3.8.2. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.3.8.3. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
- 8.4.2. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.4.3. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.4.4. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.4.5. China
- 8.4.5.1. China Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.4.5.2. China Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.4.5.3. China Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.4.6. Japan
- 8.4.6.1. Japan Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.4.6.2. Japan Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.4.6.3. Japan Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.4.7. India
- 8.4.7.1. India Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.4.7.2. India Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.4.7.3. India Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.4.8.2. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.4.8.3. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
- 8.5.2. Latin America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.5.3. Latin America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.5.4. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.5.5. Brazil
- 8.5.5.1. Brazil Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.5.5.2. Brazil Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.5.5.3. Brazil Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.5.6. Rest of Latin America
- 8.5.6.1. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.5.6.2. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.5.6.3. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.6. Middle East and Africa
- 8.6.1. Middle East and Africa Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
- 8.6.2. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
- 8.6.3. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
- 8.6.4. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
- 8.1. Global Monoclonal Antibody Therapeutics Market: Regional Overview
- Chapter 9. Company Profile
- 9.1. Pfizer Inc.
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. Bayer AG
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. Sanofi
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Developments
- 9.4. Merck & Co., Inc.
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Developments
- 9.5. GlaxoSmithKline Plc.
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Developments
- 9.6. F. Hoffmann-La Roche Ltd.
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Developments
- 9.7. Novartis AG
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Developments
- 9.8. Holdings AbbVie Inc.
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Developments
- 9.1. Pfizer Inc.
Table Of Figures
List of Figures
1. Market Research Process
2. Market Research Methodology
3. Global Monoclonal Antibody Therapeutics Market Revenue, 2015 – 2023 (USD Billion)
4. Porter’s Five Forces Analysis
5. Monoclonal Antibody Therapeutics Market Attractiveness Analysis, by Application Segment
6. Monoclonal Antibody Therapeutics Market Attractiveness Analysis, by Source Segment
7. Monoclonal Antibody Therapeutics Market Attractiveness Analysis, by End-User Segment
8. Monoclonal Antibody Therapeutics Market: Market Attractiveness Analysis, by Regional Segment
9. Company Market Share Analysis, 2017
10. Global Monoclonal Antibody Therapeutics Market Revenue Share by Application, 2017 And 2023
11. Global Monoclonal Antibody Therapeutics Market for Cancer, 2015 – 2023 (USD Billion)
12. Global Monoclonal Antibody Therapeutics Market for Autoimmune Diseases, 2015 – 2023 (USD Billion)
13. Global Monoclonal Antibody Therapeutics Market for Infection, 2015 – 2023 (USD Billion)
14. Global Monoclonal Antibody Therapeutics Market for Hematological Diseases, 2015 – 2023 (USD Billion)
15. Global Monoclonal Antibody Therapeutics Market for Others, 2015 – 2023 (USD Billion)
16. Global Monoclonal Antibody Therapeutics Market Revenue Share by Source, 2017 And 2023
17. Global Monoclonal Antibody Therapeutics Market for Human, 2015 – 2023 (USD Billion)
18. Global Monoclonal Antibody Therapeutics Market for Humanized, 2015 – 2023 (USD Billion)
19. Global Monoclonal Antibody Therapeutics Market for Chimeric, 2015 – 2023 (USD Billion)
20. Global Monoclonal Antibody Therapeutics Market for Others, 2015 – 2023 (USD Billion)
21. Global Monoclonal Antibody Therapeutics Market Revenue Share by End User, 2017 And 2023
22. Global Monoclonal Antibody Therapeutics Market for Hospitals, 2015 – 2023 (USD Billion)
23. Global Monoclonal Antibody Therapeutics Market for Private Clinics, 2015 – 2023 (USD Billion)
24. Global Monoclonal Antibody Therapeutics Market for Research Institutes, 2015 – 2023 (USD Billion)
25. North America Monoclonal Antibody Therapeutics Market, 2015-2023 (USD Billion)
26. Europe Monoclonal Antibody Therapeutics Market, 2015-2023 (USD Billion)
27. Asia Pacific Monoclonal Antibody Therapeutics Market, 2015-2023 (USD Billion)
28. Latin America Monoclonal Antibody Therapeutics Market, 2015-2023 (USD Billion)
29. Middle East and Africa Monoclonal Antibody Therapeutics Market, 2015-2023 (USD Billion)
Table Of Tables
List of Tables
1. Monoclonal Antibody Therapeutics Market: Market Snapshot
2. Drivers of Global Monoclonal Antibody Therapeutics Market: Impact Analysis
3. Restraints of Global Monoclonal Antibody Therapeutics Market: Impact Analysis
4. North America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
5. North America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
6. North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
7. U.S. Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
8. U.S. Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
9. U.S. Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
10. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
11. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
12. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
13. Europe Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
14. Europe Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
15. Europe Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
16. UK Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
17. UK Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
18. UK Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
19. Germany Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
20. Germany Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
21. Germany Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
22. France Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
23. France Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
24. France Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
25. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
26. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
27. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
28. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
29. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
30. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
31. China Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
32. China Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
33. China Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
34. Japan Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
35. Japan Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
36. Japan Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
37. India Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
38. India Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
39. India Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
40. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
41. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
42. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
43. Latin America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
44. Latin America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
45. Latin America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
46. Brazil Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
47. Brazil Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
48. Brazil Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
49. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
50. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
51. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
52. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 – 2023 (USD Billion)
53. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 – 2023 (USD Billion)
54. The Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 – 2023 (USD Billion)
Methodology
FrequentlyAsked Questions
Monoclonal antibodies (mAbs) are laboratory-produced proteins that mimic the immune system's ability to fight off harmful pathogens, such as viruses or cancer cells. They are designed to target specific proteins or antigens on the surface of these cells and neutralize their activity.
Global Monoclonal Antibody Therapeutics market size earned $231.48 B in 2023 and is expected to hit $706.52 B by 2032, with a projected CAGR of 13.2%.
The main drivers of growth in the monoclonal antibody therapeutics market include increasing prevalence of chronic diseases, rising demand for personalized medicine, growing investments in research and development activities, and increasing adoption of mAbs in emerging markets.
Some of the major challenges faced by the monoclonal antibody therapeutics market include high costs associated with the development and manufacturing of these drugs, stringent regulatory requirements, and the emergence of biosimilars and other competing therapies.
Some of the key players in the monoclonal antibody therapeutics market include Pfizer Inc., Bayer AG, Sanofi, Merck & Co., Inc., GlaxoSmithKline Plc., F. Hoffmann-La Roche Ltd., Novartis AG, and AbbVie Inc.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed